Zhuhai Huajin Capital
Huajin Capital, based in Zhuhai, specializes in equity investment and asset management. The firm manages multiple venture capital funds, including Huajin Alpha Fund II and Huajin Alpha RMB Fund I, which focus on various sectors such as healthcare, technology, high-end equipment manufacturing, cultural media, and energy conservation. Through its investment strategies, Huajin Capital aims to support growth in these industries while also engaging in incubator activities to foster new business developments. The firm’s approach is characterized by a commitment to identifying and nurturing opportunities within China's evolving market landscape.
Sunwoda Electronic Co., Ltd is a prominent manufacturer specializing in the research, design, production, and sale of lithium-ion battery modules. Founded in 1997 and headquartered in Shenzhen, China, the company offers a diverse range of products, including portable power batteries, automobile battery systems, and power management solutions. Sunwoda's lithium-ion batteries are utilized in various applications, such as mobile phones, notebooks, electric vehicles, wearable devices, drones, and energy storage systems. Additionally, the company provides integrated energy solutions, automation services, and laboratory testing. With a focus on innovation and quality, Sunwoda Electronic continues to play a significant role in the global battery market.
Cygnus Semi is a semiconductor chip technology company that focuses on 5G IoT applications.
Core Long March Technology is a high-tech design company specializing in the development of new power semiconductor devices. Its core business includes: coolmos, SiC and other chip products and technology development. The technical team is based on the technical experts of the Chinese Academy of Sciences and the introduction of outstanding overseas technical elites. The core members of the team have more than 6 years of product development experience, and realize the whole chain from chip design, manufacturing process, packaging and testing, reliability and application. The company has a professional marketing and operation management team. It is very familiar with the technology, industry and market in this direction and has good operational capabilities. The technical and management teams have gone through the process from technology development to sample to product to mass production to complete marketization. .
Researcher and developer of pharmaceutical drugs. The company develops ophthalmic drugs, small molecule immune drugs, and cell therapies based on gene editing, providing innovative products to ophthalmology, medical beauty and pet medicine.
MabPlex International Ltd provides contract development and manufacturing of biopharmaceuticals including, monoclonal antibodies (mAbs), recombinant proteins, Antibody Drug Conjugates (ADCs) and bispecifics. It offers customized mammalian cell medium, cell banking, monoclonal antibodiy active pharmaceutical ingredient (API) manufacturing, and biologics and ADC fill and finish manufacturing. The company was founded in 2013 and is based in Yantai, China with an additional office in Fremont, California.
Mabwell (Shanghai) Bioscience Co., Ltd. is a biopharmaceutical company founded in 2017 and based in Shanghai, China. It specializes in the research, development, manufacturing, and sales of macromolecular drugs, including therapeutic monoclonal antibodies, vaccines, and long-acting recombinant proteins. The company's product pipeline encompasses over thirty drug varieties targeting conditions such as tumors, autoimmunity, infections, and ophthalmic diseases. Currently, six of these products are in clinical development, with three advancing to Phase III clinical trials. Mabwell has established a strong presence in the biopharmaceutical sector by integrating multiple R&D and production enterprises within the Zhangjiang Hi-Tech Park.
Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.
Insta360 is a technology company founded in 2014 that specializes in the development of advanced camera systems designed to help individuals capture and share their experiences. Based in Shenzhen, the company has established itself as a leader in the 360-degree camera market, offering a range of products tailored for different needs, from professional-grade models like the 8K Insta360 Pro to versatile options such as the Insta360 ONE. These cameras allow users to take high-definition 360-degree photos and videos, as well as live-stream their experiences on popular social media platforms. Insta360 also produces lightweight, portable cameras and attachments for mobile devices, catering to various scenarios including vlogging and cinematic virtual reality. The company is committed to pushing the boundaries of performance and accessibility, enabling users to create immersive content that transports viewers into new experiences.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.